Boehringer Ingelheim Pharms., Inc. v. Dep't of Health & Hum. Servs.
2nd Cir. Rejects HHS Interpretation of 340B Drug Program Rules
Boehringer Ingelheim Pharms., Inc. v. Dep't of Health & Hum. Servs., decided by Second Circuit on August 7, 2025, resulted in a reversed outcome. The Second Circuit reviewed the Department of Health a...